ea0067gp18 | Poster Presentations | EYES2019
Beltsevich Dmitry
, Rosyakova Anna
, Selivanova Lilia
, Tarbaeva Natalia
Background: Adrenocortical carcinoma (ACC) is a rare malignant tumor with a poor prognosis. The only curative therapy is complete surgery (R0). A 5-year local recurrence and distant metastasis rate after R0 is 8085%. Mitotane is widely used as an adjuvant treatment in patients with a high risk of recurrence. According to the most studies, it can delay and possibly prevent a recurrence of the disease in 3550%. However, its efficacy is controversial, as well as the o...